Kaiser Permanente calls on FDA and Congress to firm up accelerated approval requirements

While FDA is implementing new accelerated approval reforms, Kaiser Permanente says the reforms do not go far enough.

The health system, which owns an insurer …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Gene therapy pioneer Jim Wilson believes he can commercialize rare-disease drugs in a tough climate

If you’d told Jim Wilson three years ago that he’d be stepping down as director of the University of Pennsylvania’s storied Gene Therapy Program, he

August 22, 2024

Pioneering study links testicular cancer among military personnel to ‘forever chemicals’

Gary Flook served in the Air Force for 37 years, as a firefighter at the now-closed Chanute Air Force Base in Illinois and the former

August 9, 2023

SPY Stock analysis and why SPY stock may start selling soon

September 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.